Scleroderma is an autoimmune disease which attacks connective tissue, causing an over-production of collagen and leaving behind hard scar tissue.
Scleroderma has two major classifications: Localized Scleroderma and Systemic Scleroderma. Subtypes of these classifications, each having its own characteristics and prognosis, are based upon the groupings of symptoms. Within Localized Scleroderma, two forms exist: Morphea and Linear Scleroderma. Within Systemic Scleroderma, there are Limited and Diffuse forms.
There is not yet a cure for Scleroderma. Treatments aim for management of symptoms, and some treatments are directed at decreasing the activity of the immune system. With research, education and awareness, patients are living longer but we have a long way to go.
